Remedent, Inc.
REMI
$0.0241
-$0.0028-10.41%
OTC PK
| 03/31/2021 | 12/31/2020 | 09/30/2020 | 06/30/2020 | 03/31/2020 | |
|---|---|---|---|---|---|
| Revenue | 35.04% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 35.04% | -- | -- | -- | -- |
| Cost of Revenue | 75.16% | -- | -- | -- | -- |
| Gross Profit | 9.60% | -- | -- | -- | -- |
| SG&A Expenses | -18.06% | -- | -- | -- | -- |
| Depreciation & Amortization | -49.04% | -- | -- | -- | -- |
| Other Operating Expenses | 17.54% | -- | -- | -- | -- |
| Total Operating Expenses | 2.26% | -- | -- | -- | -- |
| Operating Income | 105.46% | -- | -- | -- | -- |
| Income Before Tax | 109.67% | -- | -- | -- | -- |
| Income Tax Expenses | -57.14% | -- | -- | -- | -- |
| Earnings from Continuing Operations | 109.25% | -- | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 200.00% | -- | -- | -- | -- |
| Net Income | 109.48% | -- | -- | -- | -- |
| EBIT | 105.46% | -- | -- | -- | -- |
| EBITDA | 2,160.00% | -- | -- | -- | -- |
| EPS Basic | 122.56% | -- | -- | -- | -- |
| Normalized Basic EPS | 120.00% | -- | -- | -- | -- |
| EPS Diluted | 119.56% | -- | -- | -- | -- |
| Normalized Diluted EPS | 120.00% | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 0.00% | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 0.00% | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |